
Nemaura Medical Investor Relations Material
Latest events

Q2 2024
13 Nov, 2023

Q1 2024
14 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nemaura Medical Inc
Access all reports
Nemaura Medical Inc. is a medical technology company focused on the development and commercialization of non-invasive wearable devices for monitoring chronic conditions. Its flagship product is a continuous glucose monitoring system designed to help people with diabetes manage their blood sugar levels without the need for traditional fingerstick tests. Nemaura Medical leverages advanced sensor technology to provide real-time health data, supporting both patients and healthcare providers in managing diabetes and other metabolic disorders. The company is headquartered in Loughborough, England, and its shares are listed on the Nasdaq.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
NMRD
Country
🇺🇸 United States